Ann: Quarterly Activities Report and Appendix 4C, page-142

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 142 Last

Share
Profile

Follow
ravanelli77

2,888 Posts.

285

30/10/20

16:50

Post #: 48536222
Share

Originally posted by showie: ↑

2 glaring issues for DX that I believe RAP needs to fix:

1) Tony is still talking about DX as an "ADD-ON":
DX is only available to Telehealth providers (Coviu and Phenix) as a 3rd party add-on is very disappointing.
Doctors are not going to download add-ons. I wouldn't want my GP using a 3rd party app to diagnose me either- I personally would not trust it.
DX needs to be integrated into the platforms and backed by the providers to offer training / education on its use.

2) Branding:
The current implementation does not instill confidence for consumers or doctors - If DX was branded as a clinically validated "virtual stethoscope" and integrated into an established platform (Healthdirect or Coviu) I think it would have far better uptake.

"Virtual stethoscope" works as both consumers and doctors will immediately understand what it's for and what gap it fills in a teleheath setting.
The Stethoscope has been a trusted clinical tool for almost 200 years and is still used in most respiratory consultations. Who would trust a doctor to diagnose their respiratory condition without using one.

Feel free to email these suggestions to Tony

Expand

It could be too challenging for mgt. the only thing RAP needs is a board change. Simple as that. IMO

@Bloky could you pls post some articles how big telehealth spendings will be in the future. Just now we catched 3000 AUS from the cake. LOL

but also Rav was wrong expecting 0 revenues in 2020. LOL

Last edited by ravanelli77: 30/10/20

RAP Price at posting: 9.0¢ Sentiment: Sell Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

IMA

Issues emerging as Australian companies tackle critical minerals challenge

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 104 more messages in this thread...

First 142 Last

Add RAP (ASX) to my watchlist

Ann: Quarterly Activities Report and Appendix 4C, page-142

Top Stories

Cauldron Energy reports "excellent" uranium assays in latest drill run

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Issues emerging as Australian companies tackle critical minerals challenge

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News